← Back to Search

Intervention for Cardiovascular Risk (HHMB Trial)

N/A

Waitlist Available

Led By Gail Wyatt, PhD

Research Sponsored by University of California, Los Angeles

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up three-month follow-up

Awards & highlights

HHMB Trial Summary

This trial will help increase patient and organizational readiness to address trauma and cardiovascular disease risk among African American and Latino persons living with HIV or AIDS.

Eligible Conditions

Cardiovascular Risk
HIV/AIDS
Psychological Trauma

HHMB Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ three-month follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~three-month follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and three-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change from baseline in CVD Risk - Life's Simple Seven

Change from baseline in Difficulties in Emotional Regulation (DERS)

Change from baseline in PROMIS V1.2 - Global Health

+5 more

Secondary outcome measures

Change from baseline in ASCVD Risk Score

Change from baseline in AUDIT-C

Change from baseline in Beck Depression Inventory-II

+6 more

HHMB Trial Design

1Treatment groups

Experimental Treatment

Group I: InterventionExperimental Treatment1 Intervention

Hybrid type II effectiveness/implementation study design - pre-post design with each participant serving as his or her own control.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

HHMB

2019

N/A

~210

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor

1,528 Previous Clinical Trials

10,276,649 Total Patients Enrolled

3 Trials studying Cardiovascular Risk

2,122 Patients Enrolled for Cardiovascular Risk

National Heart, Lung, and Blood Institute (NHLBI)NIH

3,834 Previous Clinical Trials

47,310,433 Total Patients Enrolled

11 Trials studying Cardiovascular Risk

15,508 Patients Enrolled for Cardiovascular Risk

Gail Wyatt, PhDPrincipal InvestigatorUniversity of California, Los Angeles

1 Previous Clinical Trials

1,070 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How extensive is the scope of this medical investigation?

"Yes, according to the information on clinicaltrials.gov this investigation is presently enlisting participants with an inception date of October 1st 2019 and a last update of April 11th 2022. The study requires 260 patients from two distinct locations."

Answered by AI

What openings exist for those wishing to participate in this trial?

"As per the details listed on clinicaltrials.gov, this medical trial is still open for enrollment and has been updated as recently as April 11th 2022. It was first made available to prospective participants in October 2019."

Answered by AI

What potential outcomes is this clinical trial hoping to demonstrate?

"The primary goal of this clinical study, which will be monitored from the start date, is to observe any alteration in Difficulties in Emotional Regulation (DERS). Additionally, researchers intend to measure Pittsburgh Sleep Quality Index (PSQI), Post-traumatic Stress (PDS-5) and CAGE-AID scores as secondary outcomes. The latter two tools are employed to estimate PTSD severity while CAGE-AID serves as a brief screening tool for alcohol and drug issues."

Answered by AI

Recent research and studies

Progress in Cardiovascular DiseasesJournal

Enhancing Patient and Organizational Readiness for Cardiovascular Risk Reduction Among Black and Latinx Patients Living with HIV: Study Protocol

Hamilton, Alison B., Arleen Brown, Tamra Loeb, Dorothy Chin, Cheryl Grills, Michele Cooley-Strickland, Honghu H. Liu, and Gail E. Wyatt. 2020. “Enhancing Patient and Organizational Readiness for Cardiovascular Risk Reduction Among Black and Latinx Patients Living with HIV: Study Protocol”. Progress in Cardiovascular Diseases. Elsevier BV. doi:10.1016/j.pcad.2020.02.014.

clinicaltrials.govStudy

Healing Our Hearts Minds and Bodies: CVD Reduction in Persons With HIV

Arleen F. Brown, MD, PhD 2019. "Healing Our Hearts Minds and Bodies: CVD Reduction in Persons With HIV". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04025463.